Investment Analysts’ Updated EPS Estimates for January 9th (ACCD, ACI, AX, COST, CTNM, FLYW, GMED, LITE, LQDA, NDAQ)

Investment Analysts’ updated eps estimates for Thursday, January 9th:

Accolade (NASDAQ:ACCD) had its market perform rating reaffirmed by analysts at Raymond James.

Albertsons Companies (NYSE:ACI) had its outperform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $26.00 price target on the stock.

Axos Financial (NYSE:AX) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $85.00 price target on the stock.

Costco Wholesale (NASDAQ:COST) had its outperform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $1,100.00 target price on the stock.

Contineum Therapeutics (NASDAQ:CTNM) had its outperform rating reiterated by analysts at Royal Bank of Canada. They currently have a $31.00 price target on the stock.

Flywire (NASDAQ:FLYW) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $25.00 target price on the stock.

Globus Medical (NYSE:GMED) had its hold rating reiterated by analysts at Needham & Company LLC.

Lumentum (NASDAQ:LITE) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $110.00 target price on the stock.

Liquidia (NASDAQ:LQDA) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $19.00 price target on the stock.

Nasdaq (NASDAQ:NDAQ) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $95.00 target price on the stock.

Tamboran Resources (NYSE:TBN) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $31.00 target price on the stock.